Superior Therapeutic Efficacy of Nanoparticle Albumin Bound Paclitaxel Over Cremophor-Bound Paclitaxel in Experimental Esophageal Adenocarcinoma

Esophageal adenocarcinoma (EAC) is the fastest growing cancer in the western world and the overall 5 year survival rate of EAC is below 20%. Most patients with EAC present with locally advanced or widespread metastatic disease, where current treatment is largely ineffective. Therefore, new therapeut...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Transl Oncol
Autors principals: Hassan, Md Sazzad, Awasthi, Niranjan, Li, Jun, Williams, Fiona, Schwarz, Margaret A., Schwarz, Roderich E., von Holzen, Urs
Format: Artigo
Idioma:Inglês
Publicat: Neoplasia Press 2018
Matèries:
Original article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5884213/
https://ncbi.nlm.nih.gov/pubmed/29475139
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.tranon.2018.01.022
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars